<?xml version="1.0" encoding="UTF-8"?>
<p>Cholinesterase inhibitor has been widely accepted as one of the effective strategies for symptomatic treatment of AD
 <xref rid="CIT0020" ref-type="bibr">
  <sup>20</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0021" ref-type="bibr">
  <sup>21</sup>
 </xref>. As the disease progress, the activities of AChE declines in certain brain regions to 10â€“15% of normal activities, whereas BChE activities rise to partially compensate for the loss in AChE activities. Current available drugs for the treatment of AD predominantly are AChE inhibitors. Some investigations showed that BChE might possess as an interesting target for the treatment of AD
 <xref rid="CIT0022" ref-type="bibr">
  <sup>22</sup>
 </xref>.
</p>
